Complete Filing Data
MUSTANG BIO, INC. reported Stockholders Equity of $9.53 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MUSTANG BIO, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income Loss | -$2.4M | -$16.2M | -$49.3M | -$76.2M | -$66.7M | -$56.8M | -$45.9M | -$31.2M | -$31.8M | -$11.4M | -$2.3M |
| Net Income Loss | -$1.9M | -$15.8M | -$51.6M | -$77.5M | -$66.4M | -$60.0M | -$46.4M | -$30.7M | -$31.3M | -$12.7M | -$2.3M |
| Nonoperating Income Expense | $511.0K | $493.0K | -$2.3M | -$1.4M | $353.0K | -$3.2M | -$504.0K | $561.0K | $497.0K | -$1.3M | $0.00 |
| General And Administrative Expense | $3.9M | $4.1M | $9.7M | $12.2M | $11.0M | $9.5M | $9.6M | $6.8M | $11.4M | $2.8M | |
| Operating Expenses | $2.4M | $16.2M | $49.3M | $76.2M | $66.7M | $56.8M | $45.9M | $31.2M | $31.8M | $11.4M | |
| Research And Development Expense Excluding Acquired In Process Cost | $7.6M | $40.5M | $62.5M | $49.9M | $37.2M | $30.0M | $21.1M | $7.9M | $2.5M | ||
| Interest Expense Debt | $5.0K | $4.1M | $3.4M | $15.0K | $3.9M | $1.8M | $8.0K | $8.0K | $895.0K | ||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $861.0K | $527.0K | $1.5M | $5.8M | $10.1M | $6.3M | $3.4M | $2.9M | $0.00 | ||
| Research And Development License In Accounts Payable And Accrued Expense | $0.00 | $250.0K | $50.0K | $365.0K | $1.6M | $2.5M | $1.4M | $1.3M | |||
| Research And Development In Process | $3.4M | $12.4M | $6.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income Loss | -$624.0K | -$885.0K | -$253.0K | -$1.5M | -$8.5M | -$5.2M | -$10.3M | -$13.9M | -$16.3M | -$18.8M | -$18.2M | -$19.6M | -$17.1M | -$14.4M | -$15.1M | -$10.4M | -$14.1M | -$11.5M | -$15.9M | -$10.0M | -$10.2M | -$9.8M | -$11.9M | -$7.7M | -$5.2M | -$6.5M | -$15.7M | -$7.1M | -$5.7M | -$3.3M | -$7.8M | -$1.7M | -$1.0M | -$822.0K | -$843.0K | -$658.0K | -$537.0K |
| Net Income Loss | -$468.0K | -$762.0K | -$153.0K | -$1.4M | -$8.2M | -$5.2M | -$10.1M | -$16.2M | -$16.7M | -$19.0M | -$19.1M | -$19.8M | -$17.0M | -$14.4M | -$15.0M | -$13.0M | -$14.6M | -$11.9M | -$16.2M | -$10.2M | -$10.4M | -$9.6M | -$11.8M | -$7.5M | -$5.1M | -$6.3M | -$15.6M | -$6.9M | -$5.5M | -$3.2M | -$8.7M | -$1.9M | -$1.1M | -$903.0K | -$911.0K | -$716.0K | -$579.0K |
| Nonoperating Income Expense | $156.0K | $123.0K | $100.0K | $47.0K | $341.0K | $40.0K | $249.0K | -$2.3M | -$372.0K | -$149.0K | -$858.0K | -$157.0K | $72.0K | $81.0K | $130.0K | -$2.5M | -$477.0K | -$337.0K | -$286.0K | -$172.0K | -$187.0K | $141.0K | $130.0K | $138.0K | $147.0K | $146.0K | $129.0K | $144.0K | $136.0K | $88.0K | -$917.0K | -$200.0K | -$93.0K | -$81.0K | -$68.0K | -$58.0K | -$42.0K |
| General And Administrative Expense | $957.0K | $787.0K | $1.2M | $1.4M | $1.5M | $1.4M | $2.1M | $3.1M | $2.3M | $3.4M | $3.1M | $3.3M | $2.4M | $2.5M | $3.5M | $2.2M | $3.0M | $2.0M | $2.0M | $3.2M | $2.3M | $1.3M | $1.7M | $2.1M | $4.6M | $1.7M | $2.0M | $1.1M | $458.0K | $255.0K | $88.0K | ||||||
| Operating Expenses | $624.0K | $885.0K | $253.0K | $1.5M | $8.5M | $5.2M | $10.3M | $13.9M | $16.3M | $18.8M | $18.2M | $19.6M | $17.1M | $14.4M | $15.1M | $10.4M | $14.1M | $11.5M | $10.0M | $10.2M | $9.8M | $7.7M | $5.2M | $6.4M | $7.1M | $5.7M | $3.3M | $1.7M | $1.0M | $658.0K | |||||||
| Research And Development Expense Excluding Acquired In Process Cost | $57.0K | $4.4M | $3.8M | $9.5M | $10.8M | $14.0M | $15.4M | $15.2M | $16.3M | $14.1M | $10.9M | $11.6M | $8.0M | $9.8M | $9.3M | $7.3M | $6.8M | $7.0M | $5.3M | $3.6M | $4.3M | $2.2M | $2.5M | $706.0K | $569.0K | $582.0K | $567.0K | $570.0K | |||||||||
| Interest Expense Debt | $1.0K | $2.0K | $1.0K | $4.0K | $2.9M | $1.2M | $1.0M | $935.0K | $230.0K | $3.0K | $4.0K | $4.0K | $2.7M | $619.0K | $600.0K | $578.0K | $574.0K | $11.0K | $0.00 | $0.00 | $0.00 | $0.00 | $156.0K | $0.00 | |||||||||||||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $50.0K | $40.0K | $630.0K | $1.0M | $0.00 | $287.0K | $1.3M | $250.0K | $700.0K | $200.0K | $450.0K | $1.0M | $75.0K | $575.0K | $0.00 | ||||||||||||||||||||||
| Research And Development License In Accounts Payable And Accrued Expense | $0.00 | $250.0K | $450.0K | ||||||||||||||||||||||||||||||||||
| Research And Development In Process | $200.0K | $450.0K | $1.0M | $0.00 | $75.0K | $300.0K | $1.5M | $575.0K | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $9.5M | -$3.9M | $123.0K | $46.3M | $112.4M | $98.4M | $51.7M | $36.4M | $59.8M | $24.3M | -$4.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $17.3M | $6.8M | $7.0M | $76.7M | $110.6M | $98.8M | $62.4M | $17.0M | $35.5M | $27.5M | $0.00 |
| Retained Earnings Accumulated Deficit | -$398.6M | -$396.7M | -$381.0M | -$329.4M | -$251.8M | -$185.5M | -$125.5M | -$79.1M | -$48.4M | -$17.1M | -$4.5M |
| Liabilities And Stockholders Equity | $17.6M | $9.3M | $17.7M | $92.4M | $125.2M | $109.9M | $73.4M | $42.8M | $63.5M | $27.5M | $0.00 |
| Liabilities | $8.1M | $13.2M | $17.6M | $46.1M | $12.8M | $11.5M | $21.8M | $6.4M | $3.7M | $3.2M | $4.1M |
| Common Stock Shares Subscribed But Unissued | 278.4K | 69.0K | 7.1K | 187.1K | 2.5M | 2.1M | 1.2M | 709.3K | 834.8K | 767.3K | 250.0K |
| Assets Current | $17.6M | $8.6M | $11.3M | $78.9M | $111.7M | $99.5M | $63.1M | $35.1M | $61.4M | $27.5M | $0.00 |
| Assets | $17.6M | $9.3M | $17.7M | $92.4M | $125.2M | $109.9M | $73.4M | $42.8M | $63.5M | $27.5M | $0.00 |
| Additional Paid In Capital Common Stock | $407.9M | $392.2M | $380.5M | $374.5M | $359.9M | $276.0M | $172.2M | $113.4M | $98.7M | $37.0M | $146.0K |
| Accounts Payable And Accrued Liabilities Current | $5.4M | $9.5M | $14.0M | $13.7M | $9.7M | $8.7M | $5.7M | $5.4M | $3.5M | $683.0K | $15.0K |
| Common Stock Shares Subscriptions | 273.0K | 611.0K | 591.0K | 1.1M | 4.3M | 7.9M | 4.9M | 2.1M | 9.6M | 4.4M | 190.0K |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Liabilities Current | $7.9M | $12.6M | $15.4M | $15.1M | $10.8M | $9.5M | $7.8M | $5.6M | $3.6M | $3.2M | $4.1M |
| Cash And Cash Equivalents At Carrying Value | $17.3M | $6.8M | $6.2M | $75.7M | $109.6M | $97.8M | $61.4M | $16.5M | |||
| Other Assets Noncurrent | $0.00 | $250.0K | $833.0K | $261.0K | $362.0K | $250.0K | $250.0K | $271.0K | $251.0K | $0.00 | |
| Restricted Cash Noncurrent | $0.00 | $750.0K | $1.0M | $1.0M | $1.0M | $1.0M | $500.0K | $500.0K | $0.00 | ||
| Operating Lease Right Of Use Asset | $0.00 | $81.0K | $1.6M | $2.9M | $1.1M | $1.1M | $1.2M | $0.00 | |||
| Stock Issued During Period Value Equity Fee On At Market Offering | $395.0K | $329.0K | $114.0K | $166.0K | $1.9M | $1.5M | $495.0K | ||||
| Amortization Of Debt Discount Premium | $0.00 | $118.0K | $470.0K | $0.00 | $2.3M | $710.0K | $0.00 | $0.00 | $763.0K | ||
| Prepaid Expense And Other Assets Current | $110.0K | $200.0K | $1.2M | $2.9M | $2.0M | $1.7M | $1.6M | $1.1M | |||
| Operating Lease Liability Noncurrent | $0.00 | $422.0K | $2.0M | $3.3M | $1.7M | $2.0M | $1.8M | $0.00 | |||
| Operating Lease Liability Current | $0.00 | $456.0K | $520.0K | $612.0K | $348.0K | $278.0K | $257.0K | $0.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $10.4M | -$145.0K | -$69.7M | -$34.0M | $11.8M | $36.4M | $45.4M | -$18.5M | |||
| Property Plant And Equipment Excluding Assets Under Construction | $8.4M | $9.0M | $7.5M | $6.8M | $6.5M | $140.0K | $0.00 | ||||
| Other Receivables | $3.9M | $50.0K | $15.0K | $19.0K | $0.00 | ||||||
| Operating Lease Right Of Use Asset Amortization Expense | $7.0K | $152.0K | $365.0K | $308.0K | $139.0K | $108.0K | |||||
| Deferred Income Noncurrent | $150.0K | $150.0K | $270.0K | $270.0K | $270.0K | $0.00 | |||||
| Issuance Of Common Shares Equity Fee On At Market Offering | 0.00 | 166.0K | 1.9M | 1.5M | 495.0K | 0.00 | |||||
| Common Stock Value | $4.0K | $3.0K | $3.0K | $2.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q4 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $9.8M | $2.9M | $3.6M | -$8.7M | -$8.3M | -$4.9M | $4.0M | $13.7M | $29.8M | $64.3M | $82.0M | $97.3M | $122.2M | $135.0M | $133.4M | $76.4M | $71.0M | $45.8M | $62.4M | $71.4M | $28.5M | $45.0M | $51.6M | $55.6M | $65.1M | $69.1M | $74.2M | $3.3M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $19.0M | $12.7M | $14.2M | $3.9M | $4.6M | $1.7M | $10.3M | $16.1M | $58.8M | $92.4M | $108.4M | $123.2M | $121.9M | $130.9M | $130.4M | $76.3M | $86.4M | $56.8M | $73.3M | $83.1M | $36.1M | $18.8M | $12.2M | $18.3M | $33.2M | $53.8M | $75.0M | ||||||||
| Retained Earnings Accumulated Deficit | -$398.1M | -$397.6M | -$396.9M | -$395.8M | -$394.4M | -$386.2M | -$372.4M | -$362.3M | -$346.1M | -$309.7M | -$290.7M | -$271.6M | -$231.8M | -$214.8M | -$200.4M | -$164.9M | -$151.9M | -$137.3M | -$109.3M | -$99.1M | -$88.7M | -$67.3M | -$59.8M | -$54.7M | -$32.8M | -$25.9M | -$20.3M | -$8.4M | |||||||
| Liabilities And Stockholders Equity | $19.4M | $13.0M | $14.9M | $7.2M | $8.5M | $14.6M | $20.6M | $29.1M | $73.6M | $108.8M | $121.9M | $137.0M | $134.7M | $143.2M | $141.8M | $86.1M | $96.8M | $68.6M | $83.8M | $92.6M | $50.5M | $49.5M | $55.7M | $61.1M | $67.9M | $73.8M | $75.0M | $11.1M | |||||||
| Liabilities | $9.6M | $10.2M | $11.3M | $15.8M | $16.8M | $19.5M | $16.6M | $15.4M | $43.8M | $44.5M | $39.9M | $39.6M | $12.5M | $8.2M | $8.5M | $9.7M | $25.8M | $22.8M | $21.4M | $21.2M | $22.0M | $4.5M | $4.1M | $5.4M | $2.8M | $4.8M | $811.0K | $7.8M | |||||||
| Common Stock Shares Subscribed But Unissued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.0K | 0.00 | 0.00 | 7.0K | 41.7K | 27.4K | 13.8K | 52.0K | 63.7K | 65.8K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Assets Current | $19.4M | $13.0M | $14.9M | $6.1M | $7.3M | $9.2M | $13.6M | $22.6M | $61.1M | $94.4M | $109.4M | $124.2M | $121.9M | $131.3M | $131.0M | $75.6M | $86.3M | $57.7M | $74.4M | $83.4M | $41.6M | $41.8M | $48.1M | $55.6M | $67.7M | $73.8M | $75.0M | $11.1M | |||||||
| Assets | $19.4M | $13.0M | $14.9M | $7.2M | $8.5M | $14.6M | $20.6M | $29.1M | $73.6M | $108.8M | $121.9M | $137.0M | $134.7M | $143.2M | $141.8M | $86.1M | $96.8M | $68.6M | $83.8M | $92.6M | $50.5M | $49.5M | $55.7M | $61.1M | $67.9M | $73.8M | $75.0M | $11.1M | |||||||
| Additional Paid In Capital Common Stock | $407.9M | $400.5M | $400.5M | $387.1M | $386.0M | $381.2M | $376.4M | $376.0M | $375.9M | $374.0M | $372.7M | $368.9M | $354.0M | $349.6M | $333.6M | $241.0M | $222.9M | $183.1M | $171.7M | $170.5M | $117.2M | $112.3M | $111.4M | $110.3M | $97.9M | $94.9M | $94.5M | $11.7M | |||||||
| Accounts Payable And Accrued Liabilities Current | $6.9M | $7.5M | $8.3M | $12.1M | $13.2M | $15.0M | $12.7M | $11.7M | $11.4M | $12.8M | $10.2M | $9.6M | $9.8M | $5.8M | $6.0M | $7.1M | $9.0M | $6.1M | $5.8M | $5.5M | $6.7M | $3.8M | $3.5M | $5.0M | $2.7M | $4.5M | $766.0K | $1.0M | |||||||
| Common Stock Shares Subscriptions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.0K | 0.00 | 0.00 | 4.0K | 28.0K | 27.0K | 37.0K | 185.0K | 218.0K | 235.0K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Liabilities Current | $9.4M | $10.0M | $11.2M | $15.0M | $15.9M | $17.4M | $14.2M | $12.9M | $12.7M | $13.6M | $11.0M | $10.8M | $10.5M | $6.4M | $6.6M | $7.6M | $14.8M | $10.0M | $6.3M | $6.4M | $7.4M | $4.1M | $3.7M | $5.3M | $4.8M | $811.0K | $4.9M | ||||||||
| Cash And Cash Equivalents At Carrying Value | $19.0M | $12.7M | $14.2M | $3.5M | $4.3M | $1.3M | $9.6M | $15.4M | $58.1M | $91.4M | $107.4M | $122.2M | $120.9M | $129.9M | $129.4M | $75.3M | $85.4M | $55.8M | $72.8M | $33.2M | $53.8M | $27.5M | $11.1M | $0.00 | $0.00 | ||||||||||
| Other Assets Noncurrent | $0.00 | $0.00 | $0.00 | $250.0K | $250.0K | $530.0K | $1.1M | $253.0K | $257.0K | $320.0K | $359.0K | $286.0K | $254.0K | $255.0K | $255.0K | $250.0K | $250.0K | $250.0K | $250.0K | $250.0K | $261.0K | $394.0K | $521.0K | $594.0K | |||||||||||
| Restricted Cash Noncurrent | $375.0K | $375.0K | $375.0K | $750.0K | $750.0K | $750.0K | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | ||||||||||||||
| Operating Lease Right Of Use Asset | $0.00 | $0.00 | $0.00 | $92.0K | $103.0K | $1.5M | $1.6M | $1.7M | $2.8M | $3.0M | $970.0K | $1.0M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.2M | $1.2M | $1.2M | $1.2M | ||||||||||||||
| Stock Issued During Period Value Equity Fee On At Market Offering | $216.0K | $29.0K | $4.0K | $19.0K | $75.0K | $73.0K | $75.0K | $388.0K | $1.2M | $450.0K | $77.0K | $125.0K | $495.0K | ||||||||||||||||||||||
| Amortization Of Debt Discount Premium | $0.00 | $143.0K | $143.0K | $148.0K | $19.0K | $0.00 | $259.0K | $0.00 | |||||||||||||||||||||||||||
| Prepaid Expense And Other Assets Current | $160.0K | $172.0K | $211.0K | $84.0K | $114.0K | $1.2M | $4.0M | $2.8M | $3.0M | $3.1M | $2.0M | $1.9M | $1.0M | $1.4M | $1.6M | $344.0K | $886.0K | $1.9M | $1.5M | $660.0K | $857.0K | ||||||||||||||
| Operating Lease Liability Noncurrent | $0.00 | $0.00 | $0.00 | $541.0K | $656.0K | $1.8M | $2.1M | $2.2M | $3.3M | $3.4M | $1.5M | $1.6M | $1.8M | $1.8M | $1.9M | $2.0M | $2.1M | $2.2M | $1.9M | $1.9M | $1.9M | ||||||||||||||
| Operating Lease Liability Current | $0.00 | $0.00 | $0.00 | $442.0K | $429.0K | $570.0K | $453.0K | $409.0K | $629.0K | $595.0K | $368.0K | $358.0K | $329.0K | $346.0K | $284.0K | $271.0K | $265.0K | $257.0K | $239.0K | $157.0K | $99.0K | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $7.4M | -$5.3M | -$17.8M | $12.6M | $31.6M | -$5.6M | $19.1M | ||||||||||||||||||||||||||||
| Property Plant And Equipment Excluding Assets Under Construction | $3.0M | $3.2M | $3.5M | $3.8M | $8.3M | $9.0M | $8.7M | $8.5M | $9.4M | $7.2M | $7.1M | $7.3M | $7.7M | $7.7M | $6.5M | $6.5M | $6.4M | $6.8M | $5.7M | $133.0K | |||||||||||||||
| Other Receivables | $217.0K | $217.0K | $467.0K | $402.0K | $237.0K | $728.0K | $6.7M | $0.00 | $0.00 | $0.00 | $36.0K | $33.0K | $33.0K | $32.0K | $41.0K | $32.0K | $17.0K | $37.0K | $25.0K | $14.0K | $55.0K | $128.0K | $111.0K | ||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $7.0K | $411.0K | $106.0K | $39.0K | $28.0K | ||||||||||||||||||||||||||||||
| Deferred Income Noncurrent | $150.0K | $150.0K | $150.0K | $270.0K | $270.0K | $270.0K | $270.0K | $270.0K | $270.0K | $270.0K | $270.0K | $270.0K | $270.0K | ||||||||||||||||||||||
| Issuance Of Common Shares Equity Fee On At Market Offering | 0.00 | 73.0K | 1.2M | 125.0K | 0.00 | ||||||||||||||||||||||||||||||
| Common Stock Value | $8.0K | $7.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $1.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $14.5M | $11.3M | -$26.1M | $34.1M | $70.8M | $78.1M | $65.1M | $181.0K | $50.0M | $31.6M | |
| Investing Cash Flow * | $1.2M | $0.00 | $5.9M | -$3.0M | -$5.4M | -$4.4M | $13.9M | $557.0K | -$29.1M | $0.00 | |
| Operating Cash Flow * | -$5.3M | -$11.4M | -$49.5M | -$65.1M | -$53.7M | -$37.3M | -$33.6M | -$19.2M | -$12.9M | -$4.1M | |
| Share Based Compensation | $129.0K | -$450.0K | $568.0K | $2.3M | $3.3M | $3.0M | $2.7M | $5.0M | $2.0M | $0.00 | |
| Stock Issued During Period Value Share Based Compensation | $129.0K | -$450.0K | $568.0K | $2.3M | $3.3M | $3.0M | $2.7M | $5.0M | $2.0M | ||
| Increase Decrease In Due To Related Parties | -$164.0K | $1.8M | $67.0K | $43.0K | $233.0K | -$106.0K | $360.0K | $99.0K | $12.0K | -$250.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$90.0K | -$586.0K | -$1.1M | $1.0M | $401.0K | $84.0K | $558.0K | $757.0K | |||
| Payments To Acquire Intangible Assets | $0.00 | $50.0K | $365.0K | $1.4M | $2.5M | $1.4M | $1.1M | $2.4M | $0.00 | ||
| Increase Decrease In Lease Liabilities | $73.0K | $447.0K | $680.0K | $263.0K | $296.0K | -$128.0K | -$53.0K | $0.00 | |||
| Payments To Acquire Property Plant And Equipment | $0.00 | $64.0K | $2.7M | $4.0M | $1.9M | $2.3M | $6.9M | $424.0K | |||
| Increase Decrease In Accounts Payable And Accrued Expenses Excluding Amounts Due To Related Parties | -$2.0M | -$591.0K | $125.0K | $5.3M | -$408.0K | $3.2M | $296.0K | $2.5M | |||
| Proceeds From Issuance Of Common Shares At Market Offering | 599.0K | 2.5M | 163.0K | 6.6M | 71.9M | 59.8M | 22.5M | 0.00 | |||
| Proceeds From Stock Plans | $0.00 | $48.0K | $178.0K | $206.0K | $309.0K | $349.0K | $0.00 | ||||
| Payments Of Stock Issuance Costs | $1.4M | $443.0K | $0.00 | $2.4M | $2.1M | $0.00 | $5.7M | $4.1M | $0.00 | ||
| Increase Decrease In Other Receivables | -$435.0K | -$494.0K | -$14.0K | $35.0K | -$4.0K | $19.0K | $0.00 | ||||
| Proceeds From Warrant Exercises | $7.1M | $3.5M | $0.00 | $0.00 | $181.0K | $0.00 | |||||
| Payments Of Debt Issuance Costs | $0.00 | $2.7M | $0.00 | $0.00 | $1.4M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $7.6M | $49.0K | $0.00 | $30.2M | $47.6M | $5.1M | $13.6M | $96.0K | $49.9M | $581.0K | ||||||||||||||||||||
| Investing Cash Flow * | $1.2M | $0.00 | $0.00 | -$1.3M | -$458.0K | -$526.0K | $12.0M | -$11.8M | -$375.0K | $0.00 | ||||||||||||||||||||
| Operating Cash Flow * | -$1.4M | -$5.3M | -$17.8M | -$16.3M | -$15.6M | -$10.2M | -$6.5M | -$5.6M | -$2.0M | -$581.0K | ||||||||||||||||||||
| Share Based Compensation | $23.0K | $45.0K | $38.0K | $42.0K | -$619.0K | $76.0K | $100.0K | $45.0K | $235.0K | $496.0K | $650.0K | $664.0K | $884.0K | $547.0K | $996.0K | $606.0K | $957.0K | $805.0K | $1.1M | $622.0K | $432.0K | $903.0K | $971.0K | $2.0M | $834.0K | $397.0K | $0.00 | $0.00 | $0.00 | |
| Stock Issued During Period Value Share Based Compensation | $23.0K | $45.0K | $38.0K | $42.0K | -$619.0K | $76.0K | $100.0K | $45.0K | $235.0K | $496.0K | $650.0K | $664.0K | $884.0K | $547.0K | $996.0K | $606.0K | $957.0K | $805.0K | $1.1M | $622.0K | $432.0K | $903.0K | $971.0K | $2.0M | ||||||
| Increase Decrease In Due To Related Parties | $146.0K | $1.0M | -$165.0K | $88.0K | -$147.0K | -$50.0K | $382.0K | $179.0K | -$110.0K | $125.0K | ||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $11.0K | -$371.0K | -$131.0K | -$209.0K | -$129.0K | $246.0K | -$265.0K | $731.0K | $15.0K | |||||||||||||||||||||
| Payments To Acquire Intangible Assets | $0.00 | $200.0K | $75.0K | $375.0K | $0.00 | |||||||||||||||||||||||||
| Increase Decrease In Lease Liabilities | $73.0K | $431.0K | $42.0K | $85.0K | $69.0K | -$316.0K | $12.0K | $0.00 | ||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $1.3M | $458.0K | $526.0K | $299.0K | $676.0K | ||||||||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Expenses Excluding Amounts Due To Related Parties | -$1.4M | $997.0K | -$2.3M | $1.1M | -$3.2M | -$163.0K | $1.0M | |||||||||||||||||||||||
| Proceeds From Issuance Of Common Shares At Market Offering | 599.0K | 0.00 | 0.00 | 2.8M | 48.4M | 5.0M | 0.00 | |||||||||||||||||||||||
| Proceeds From Stock Plans | $0.00 | $48.0K | $0.00 | $116.0K | $158.0K | $169.0K | $0.00 | |||||||||||||||||||||||
| Payments Of Stock Issuance Costs | $0.00 | $5.7M | $0.00 | |||||||||||||||||||||||||||
| Increase Decrease In Other Receivables | -$185.0K | $2.9M | -$36.0K | -$18.0K | $2.0K | -$5.0K | $111.0K | $0.00 | ||||||||||||||||||||||
| Proceeds From Warrant Exercises | $0.00 | $1.0K | $0.00 | $0.00 | $0.00 | $96.0K | $0.00 | |||||||||||||||||||||||
| Payments Of Debt Issuance Costs | $0.00 | $2.6M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.39 | -$38.57 | -$299.95 | -$10.09 | -$0.76 | -$1.14 | -$1.29 | -$1.14 | -$1.24 | -$1.15 | -$0.23 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 150.0M | 125.0M | 125.0M | 85.0M | 50.0M | 50.0M | 50.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 87.9M | 52.6M | 36.1M | 26.9M | 25.3M | 11.0M | |||||
| Weighted Average Number Of Shares Outstanding Basic | 4.9M | 609.7K | 172.0K | 7.7M | 87.9M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 4.9M | 609.7K | 172.0K | 7.7M | 87.9M | ||||||
| Earnings Per Share Basic | $-0.39 | $-38.57 | $-299.95 | $-10.09 | $-0.76 | ||||||
| Common Stock Shares Issued | 39.4M | 26.6M | 25.2M | 15.2M | 2.0M | ||||||
| Common Stock Shares Outstanding | 39.4M | 26.6M | 25.2M | 15.2M | 2.0M | ||||||
| Preferred Stock Shares Outstanding | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | |||||
| Preferred Stock Shares Issued | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.07 | -$0.19 | -$0.05 | -$1.96 | -$18.36 | -$24.81 | -$1.23 | -$2.00 | -$2.06 | -$2.42 | -$2.50 | -$2.71 | -$0.19 | -$0.16 | -$0.19 | -$0.23 | -$0.32 | -$0.28 | -$0.41 | -$0.25 | -$0.29 | -$0.34 | -$0.43 | -$0.28 | -$0.19 | -$0.24 | -$0.61 | -$0.27 | -$0.21 | -$0.14 | -$0.64 | -$0.19 | -$0.11 | -$0.09 | -$0.09 | -$0.07 | -$0.06 | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 150.0M | 150.0M | 150.0M | 125.0M | 85.0M | 85.0M | 85.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||
| Preferred Stock Shares Authorized | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M | ||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 91.1M | 87.6M | 80.5M | 57.3M | 45.0M | 42.0M | 39.9M | 36.3M | 27.9M | 27.1M | 27.1M | 26.4M | 26.2M | 26.2M | 22.4M | 10.1M | 10.3M | 10.1M | 10.0M | |||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 6.2M | 4.0M | 2.9M | 720.9K | 446.6K | 209.2K | 8.2M | 8.1M | 8.1M | 7.9M | 7.7M | 7.3M | 91.1M | 87.6M | 80.5M | |||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 6.2M | 4.0M | 2.9M | 720.9K | 446.6K | 209.2K | 8.2M | 8.1M | 8.1M | 7.9M | 7.7M | 7.3M | 91.1M | 87.6M | 80.5M | |||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.07 | $-0.19 | $-0.05 | $-1.96 | $-18.36 | $-24.81 | $-1.23 | $-2.00 | $-2.06 | $-2.42 | $-2.50 | $-2.71 | $-0.19 | $-0.16 | $-0.19 | |||||||||||||||||||||||||
| Common Stock Shares Issued | 7.3M | 7.3M | 7.1M | 106.4M | 104.5M | 100.3M | 93.6M | 91.2M | 89.9M | 85.0M | 70.9M | 60.2M | 54.8M | 42.1M | 39.6M | 39.5M | 27.6M | 26.3M | 26.3M | 26.1M | 25.2M | 25.2M | 25.0M | 11.0M | ||||||||||||||||
| Common Stock Shares Outstanding | 106.4M | 104.5M | 100.3M | 93.6M | 91.2M | 89.9M | 85.0M | 70.9M | 60.2M | 54.8M | 42.1M | 39.6M | 39.5M | 27.6M | 26.3M | 26.3M | 26.1M | 25.2M | 25.2M | 25.0M | 11.0M | |||||||||||||||||||
| Preferred Stock Shares Outstanding | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | |||||||||||||||||||||||||
| Preferred Stock Shares Issued | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K | 250.0K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income Other | $511.0K | $179.0K | $850.0K | $689.0K | $368.0K | $708.0K | $1.3M | $569.0K | $505.0K | $16.0K |
| Depreciation | $34.0K | $671.0K | $1.9M | $2.7M | $2.2M | $1.7M | $1.3M | $630.0K | $2.0K | $0.00 |
| Stock Issued1 | $611.0K | $591.0K | $1.1M | $4.2M | $7.6M | $4.9M | $2.1M | $9.6M | $4.4M | $190.0K |
| Stock Issued During Period Value At Marketing Offering | $599.0K | $2.5M | $160.0K | $6.5M | $70.6M | $58.6M | $22.0M | |||
| Interest Paid Net | $0.00 | $1.3M | $2.7M | $0.00 | $1.6M | $1.1M | $0.00 | $413.0K | $140.0K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $48.0K | $178.0K | $206.0K | $309.0K | $349.0K | |||||
| Construction In Process Net | $29.0K | $951.0K | $2.0M | $499.0K | $1.2M | $393.0K | $1.2M | $0.00 | ||
| Offering Costs For Issuance Of Common Shares At Market Offering | 102.0K | 3.0K | 123.0K | 1.4M | 1.1M | 543.0K | 0.00 | |||
| Grant Income | $0.00 | $314.0K | $917.0K | $1.3M | ||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $1.3M | $31.0K | $187.0K | $196.0K | $959.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income Other | $156.0K | $123.0K | $100.0K | $47.0K | $27.0K | $40.0K | $115.0K | $159.0K | $453.0K | $216.0K | $77.0K | $73.0K | $75.0K | $85.0K | $134.0K | $162.0K | $142.0K | $263.0K | $406.0K | $387.0K | $152.0K | $138.0K | $147.0K | $146.0K | $144.0K | $134.0K | $90.0K | $0.00 | $0.00 | $0.00 |
| Depreciation | $34.0K | $100.0K | $300.0K | $285.0K | $300.0K | $600.0K | $752.0K | $700.0K | $700.0K | $640.0K | $600.0K | $500.0K | $462.0K | $400.0K | $400.0K | $373.0K | $300.0K | $300.0K | $288.0K | $200.0K | $100.0K | $7.0K | $0.00 | $0.00 | ||||||
| Stock Issued1 | $611.0K | $591.0K | $1.1M | $4.2M | $7.6M | $4.9M | $2.1M | $9.6M | $4.4M | $190.0K | ||||||||||||||||||||
| Stock Issued During Period Value At Marketing Offering | $179.0K | $599.0K | $1.1M | $160.0K | $709.0K | $3.1M | $2.7M | $3.1M | $15.1M | $47.5M | $17.2M | $2.9M | $4.9M | $22.0M | ||||||||||||||||
| Interest Paid Net | $0.00 | $1.0M | $0.00 | $0.00 | $341.0K | $0.00 | $0.00 | $413.0K | ||||||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $48.0K | $90.0K | $88.0K | $90.0K | $116.0K | $151.0K | $158.0K | $180.0K | $34.9M | $169.0K | ||||||||||||||||||||
| Construction In Process Net | $0.00 | $0.00 | $333.0K | $1.1M | $1.5M | $2.0M | $1.0M | $2.4M | $1.5M | $821.0K | $493.0K | $712.0K | $1.0M | $699.0K | $487.0K | $33.0K | $864.0K | $4.2M | ||||||||||||
| Offering Costs For Issuance Of Common Shares At Market Offering | 0.00 | 49.0K | 932.0K | 87.0K | 0.00 | |||||||||||||||||||||||||
| Grant Income | $0.00 | $0.00 | $0.00 | $314.0K | $0.00 | $138.0K | $429.0K | $351.0K | $669.0K | $0.00 | ||||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $18.0K | $35.0K | $545.0K | $540.0K | $191.0K | $2.3M |
Most recent annual filing with the SEC: March 19, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.